Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1997 Apr;46(4):701-10.
doi: 10.2337/diab.46.4.701.

Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies

S L Edelstein  1 , W C Knowler, R P Bain, R Andres, E L Barrett-Connor, G K Dowse, S M Haffner, D J Pettitt, J D Sorkin, D C Muller, V R Collins, R F Hamman
Affiliations
Comparative Study

Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies

S L Edelstein et al. Diabetes. 1997 Apr.

Abstract

Risk factors associated with the progression from impaired glucose tolerance (IGT) to NIDDM were examined in data from six prospective studies. IGT and NIDDM were defined in all studies by World Health Organization (WHO) criteria, and baseline risk factors were measured at the time of first recognition of IGT. The studies varied in size from 177 to 693 participants with IGT, and included men and women followed from 2 to 27 years after the recognition of IGT. Across the six studies, the incidence rate of NIDDM was 57.2/1,000 person-years and ranged from 35.8/1,000 to 87.3/1,000 person-years. Although baseline measures of fasting and 2-h postchallenge glucose levels were both positively associated with NIDDM incidence, incidence rates were sharply higher for those in the top quartile of fasting plasma glucose levels, but increased linearly with increasing 2-h postchallenge glucose quartiles. Incidence rates were higher among the Hispanic, Mexican-American, Pima, and Nauruan populations than among Caucasians. The effect of baseline age on NIDDM incidence rates differed among the studies; the rates did not increase or rose only slightly with increasing baseline age in three of the studies and formed an inverted U in three studies. In all studies, estimates of obesity (including BMI, waist-to-hip ratio, and waist circumference) were positively associated with NIDDM incidence. BMI was associated with NIDDM incidence independently of fasting and 2-h post challenge glucose levels in the combined analysis of all six studies and in three cohorts separately, but not in the three studies with the highest NIDDM incidence rates. Sex and family history of diabetes were generally not related to NIDDM progression. This analysis indicates that persons with IGT are at high risk and that further refinement of risk can be made by other simple measurements. The ability to identify persons at high risk of NIDDM should facilitate clinical trials in diabetes prevention.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Study-specific NIDDM incidence rates by age (A), BMI (B), fasting plasma glucose concentrations (C), and 2-h postchallenge plasma glucose concentrations (D) at the time of IGT recognition. [square bullet, filled], BLSA; *, Nauru; [shaded triangle], Pima; +, RBS; [square bullet, filled] , SAHS; [circle, open], SLVDS.
Figure 2
Figure 2
Study-specific NIDDM incidence rates by WHR at time of IGT recognition for men and women. Incidence rates were computed by study-and-sex-specific WHR quartiles and are graphed at the study-and sex-specific quartile means. [square bullet, filled], BLSA; +, RBS; [circle, open], SLVDS.
Figure 3
Figure 3
Study-specific NIDDM incidence rates by sex (A), family history of NIDDM (B), and ethnicity (C) at the time of IGT recognition.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Harris MI, Hadden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr. Diabetes. 1987;36:523–534. - PubMed
    1. Geiss LS, Herman WH, Goldschmid MG, DeStefano F, Eberhardt MS, Ford ES, German RR, Newman JM, Olson DR, Sepe SJ, Stevenson JM, Vinicor F, Wetterhall SF, Will JC. Surveillance for diabetes mellitus: United States, 1980-1989. Morb Mortal Wkly Rep. 1993;42:1–20. - PubMed
    1. Kovar MG, Harris MI, Hadden WC. The scope of diabetes in the United States population. Am J Pub Health. 1987;77:1549–1550. - PMC - PubMed
    1. Tuomilehto J, Knowler WC, Zimmet P. Primary prevention of non-insulin-dependent diabetes mellitus. Diabetes/Metab Rev. 1992;8:339–353. - PubMed
    1. Knowler WC, Narayan KMV, Hanson RL, Nelson RG, Bennett PH, Tuomilehto J, Schersten B, Pettitt DJ. Preventing non-insulin-dependent diabetes. Diabetes. 1995;44:483–488. - PubMed

Publication types

MeSH terms